Charlie Hospital Semarang Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp144 (market cap 344.57B, 9.46M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.2× Sinergi Multi Lestarindo Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 9.46M). Which is the better fit depends on your goals.
| RSCH | SMLE | |
|---|---|---|
Market Cap | 742B | 344.57B |
Volume | 29.45M | 9.46M |
Lot | 294.49K | 94.62K |
Turnover | 8.14B | 1.36B |
Average Price | 276.35 | 143.3 |
Value | 8.14B | 1.36B |
Indicative Equilibrium Price | 270 | 144 |
Indicative Equilibrium Volume | 103 | 140 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →